Products released at this year's meeting covered a broad range of applications from sustainable labware to protein assays to instruments.

We are glad that Isomorphic is helping advance the field and are able to match the level of performance we demonstrated at the ARDD conference in Copenhagen last August. In August, Deep Origin ...

Promega Corporation has introduced a new platform designed to help drug discovery scientists study some of the most challenging protein targets in living cells, enabling earlier and more reliable ...

TOKYO — An oral medicine used to treat chronic kidney disease and heart failure is also effective in treating premature ...

AIMS™ Platform valdated: Integration of AI-driven structural modeling with mass-spectrometry-based structural proteomics, which supported the lead optimization of the KAT6A Targeted Protein ...

Twist Bioscience's Q1 growth was modest, due in large part to an air pocket in demand caused by a large NGS customer. Read ...

Synthace, the leader in software and services for assay development, today announced a collaboration with Charles River Laboratories International, Inc. (Charles River), a leading global drug ...

Digital twins revolutionize drug discovery by integrating AI and biological data, enhancing prediction, trial design, and decision-making in precision medicine.

QuantX Biosciences, Inc., a computationally driven drug discovery and development company using advanced modeling and high-performance computing to rapidly design and optimize oral small molecule ...

Explore AI in drug discovery and its journey from promise to proof in 2025 with significant achievements and challenges faced.

Abstract: Traditional truth discovery methods often face scalability challenges when processing large-scale dynamic traffic data. Moreover, traffic condition data exhibit significant spatial ...